The global central nervous system drugs market reached a value of nearly $125,277.9 million in 2020, having increased at a compound annual growth rate (CAGR) of 4.6% since 2015. The market is expected to grow from $125,277.9 million in 2020 to $163,045.4 million in 2025 at a rate of 5.4%. The growth is mainly due to the increasing prevalence of psychological disorders which is expected to drive the demand for central nervous system drugs. The central nervous system (CNS) drugs market is expected to grow from $163,045.4 million in 2025 to $210,912.9 million in 2030 at a CAGR of 5.3%.
Request For The Sample Of The Central Nervous System Drugs Market Here:
The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord. The CNS drugs include anesthetics, anticonvulsants, antiemetics, antiparkinsonian agents, CNS stimulants, analgesics, and sedatives. Neurological diseases such as Epilepsy, Parkinson and psychological indications such as depression, and dementia are generally treated through these CNS drugs.
Place A Direct Purchase Order Of The Central Nervous System Drugs Report Here:
The central nervous system drugs market report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Some of the major players of the central nervous system drugs market are Biogen Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Novartis AG, UCB
The central nervous system drugs market is segmented by type, by distribution channel, by distribution channel, by drug classification, by mode of purchase.
The central nervous system drugs market is segmented by type into
- a) Multiple Sclerosis (MS)
- b) Anti-Psychotic
- c) Analgesics
- d) Anti-Parkinson Drugs
- e) Anesthetics
- f) Anti-Epileptics
- g) Anti-Depressants
- h) Other CNS Drugs
By Distribution Channel –
The central nervous system drugs market is segmented by distribution channel into
- a) Hospitals Pharmacies
- b) Retail Pharmacies/ Drug Stores
- c) Others
By Route Of Administration –
The central nervous system drugs market is segmented by route of administration into
- a) Oral
- b) Intravenous
- c) Intranasal/ Inhalation
- d) Others
By Drug Classification –
The central nervous system drugs market is segmented by drug classification into
- a) Branded Drugs
- b) Generic Drugs
By Mode Of Purchase –
The central nervous system drugs market is segmented by mode of purchase into
- a) Over-The-Counter Drugs
- b) Prescription-Based Drugs
Read More On The Global Central Nervous System Drugs Market Report:
The central nervous system drugs market report describes and explains the global central nervous system drugs market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The central nervous system drugs report evaluates the market across each region and for the major economies within each region.
The countries covered in the global central nervous system drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.
The regions covered in the global central nervous system drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Full Report Includes
- Executive Summary
- Report Structure
- Central Nervous System Drugs Market Characteristics
- Central Nervous System Drugs Market Product Analysis
- Central Nervous System Drugs Market Supply Chain
- Key Mergers And Acquisitions In The Central Nervous System Drugs Market
- Market Background: Machinery Manufacturing Market
- Copyright And Disclaimer
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model